LRP5 and gastric cancer: DKK1, a secretory antagonist that interacts with the Wnt coreceptor LRP5/6, thereby reducing cellular sensitivity to canonical Wnt ligands, has been identified as a factor that can enhance the recurrence of gastric cancer [38].